Research-informed guides to help you understand fertility after 35 — ovarian reserve, cycle tracking, ovulation testing, and preparing for informed conversations with your provider.
“Brain fog” is one of the most commonly described — and commonly dismissed — symptoms of perimenopause. Women report difficulty finding words, slower processing speed, short-term memory lapses, and a general sense of mental fuzziness that contrasts with their earlier baseline. For women in their late 30s and 40s, these experiences can be unsettling, especially … Ler mais
Estrogen is one of the body’s most influential hormones, shaping everything from menstrual cycles and mood to bone health and sleep architecture. For women in their late 30s and 40s, estrogen levels begin a gradual but often noticeable transition that unfolds over years before menopause itself. Unlike the relatively predictable cycling of estrogen in the … Ler mais
Egg quality is one of the most discussed and least understood topics in fertility conversations, particularly for women navigating reproductive planning after age 35. While the term gets mentioned often in clinical settings and online forums, what it actually means biologically and what current research suggests about it deserves a clearer, calmer look. Reproductive aging … Ler mais
The thyroid gland — a small, butterfly-shaped structure in the neck — produces hormones that regulate metabolism, energy, body temperature, and a wide range of physiological processes. What is less commonly discussed is the significant influence thyroid function has on reproductive health, including menstrual cycle regularity, ovulation, the ability to conceive, and pregnancy outcomes. Thyroid … Ler mais
A shift in menstrual cycle regularity is one of the most common reasons women in their mid-to-late thirties visit their healthcare provider. Cycles that have been relatively predictable for years may begin to change — in length, flow, or both — and the question of what this means can feel urgent, particularly for women who … Ler mais
Anti-Müllerian hormone (AMH) testing has become one of the more frequently discussed fertility assessments for women in their mid-thirties and beyond. For women thinking about their reproductive timeline — whether actively trying to conceive or simply curious about their fertility — AMH results can feel both illuminating and anxiety-inducing. Understanding what AMH actually measures, what … Ler mais
Perimenopause—the transitional phase leading up to menopause—is often discussed as something that begins in the late 40s, but research suggests many women begin experiencing subtle hormonal shifts in their late 30s and early 40s. This creates an interesting overlap: women who are still hoping to conceive may be entering the early stages of a reproductive … Ler mais
Anti-Müllerian hormone, more commonly known as AMH, has become one of the most widely discussed fertility markers in recent years. A single blood test, available directly to consumers through various labs and often ordered during fertility evaluations, seems to promise an answer to a question many women deeply want to know: how much fertility time … Ler mais
Few topics generate more questions—and more anxiety—for women trying to conceive after 35 than egg quality. The phrase appears frequently in fertility discussions, but what does current science actually tell us about egg quality, how it changes with age, and what it means for conception? Understanding the research, without the alarm that often surrounds this … Ler mais
Ovarian reserve testing has become a significant part of the fertility conversation for many women over 35. Whether you’ve encountered a low AMH number in a fertility workup, had a healthcare provider mention “diminished ovarian reserve,” or are simply trying to understand what these tests measure before you pursue them, understanding what ovarian reserve actually … Ler mais